Alcon Introduces the CENTURION® Vision System; the Only Intelligent Phacoemulsification Technology Designed to Optimize Cataract Surgery
Sep 06, 2013
CENTURION® Vision System is designed to optimize every moment of the cataract surgical procedure to improve patient outcomes
Provides control and improved efficiency during the minimally invasive cataract phacoemulsification procedure
Combines multiple technologies to set new standards in the performance of cataract surgery
FORT WORTH, Texas – September 5, 2013 – Alcon announced today the global launch of the CENTURION® Vision System, the industry’s most advanced phacoemulsification (phaco) technology platform designed to provide surgeons with superior cataract removal capabilities.
The new CENTURION® Vision System is the only intelligent phaco technology that optimizes every moment of the cataract surgical procedure. The new system automatically and continuously adapts to changing conditions within the eye, provides greater anterior chamber stability during each step of the surgery, and places optimized energy technology at the surgeon’s fingertips through enhanced fluidic management and surgical precision.1
To date, more than 40 surgeons from around the world have tested the CENTURION® Vision System for more than 2,000 cataract surgeries. Initial responses from these surgeons have been positive.
Technology Overview & Unique Features The CENTURION® Vision System sets a new standard of performance in cataract surgery by combining multiple intelligent phaco technologies, and other key features, including:
Active Fluidics™ Technology, an automated system that optimizes anterior chamber stability by allowing surgeons to proactively set and maintain target intraocular pressure (IOP) within the eye during the cataract removal procedure.1 This provides enhanced IOP control during the procedure in comparison to gravity fluidics and fixed pressure irrigation; reduces surges due to occlusion breaks; increases IOP efficiency at lower, more natural settings; and eliminates the need to manually adjust fluid pressure.
Balanced Energy™ Technology enhances phacoemulsification efficiency through proven OZil® Intelligent Phaco and the INTREPID® Balanced Tip probe. This increases efficiency and control, while reducing energy levels, and accommodating surgeon settings for aspiration and vacuum by keeping the fragmented lens material at the shearing plane for emulsification. 2,3
Applied Integration™, an innovative design that enables the new system to be seamlessly integrated with multiple cataract surgical technologies, like Alcon’s LuxOR™ Surgical Microscopes with Q-VUE™ 3-D assistant and the LenSx® Laser to create a comprehensive cataract surgery suite designed to minimize variability at every step of the procedure.
The CENTURION® Vision System also offers an improved ergonomic design, wireless footswitch and intuitive touch-screen display.
“As the world leader in eye care, Alcon is on the frontlines of delivering new innovations to help improve cataract care,” said Stephen Speares, Global Head of Cataract Franchise, Alcon. “By combining multiple proprietary technologies and unique innovations as part of the CENTURION® Vision System, we are offering surgeons the next-generation phaco platform that will enable them to optimize every step of the cataract surgery, and ultimately, help deliver exceptional patient outcomes.” The CENTURION® Vision System will become available in 2013 in those countries where the new phacoemulsification system has received the necessary regulatory approvals. Alcon will continue its global rollout throughout 2014. Live surgery demonstrations of the CENTURION® Vision System will take place during the upcoming ESCRS (European Society of Cataract and Refractive Surgeons) and AAO (American Academy of Ophthalmology) Congresses.
About Alcon Alcon, the global leader in eye care, provides innovative products that enhance quality of life by helping people worldwide see better. The three Alcon businesses - Surgical, Pharmaceutical and Vision Care - offer the widest spectrum of eye care products in the world. Alcon is the second largest division of the Novartis Group with pro-forma sales of USD 10.2 billion in 2012. Headquartered in Fort Worth, Texas, U.S.A., Alcon has more than 24,000 employees worldwide, operations in 75 countries and products available in 180 markets. For more information, visit www.alcon.com.
Media Inquiries Melissa Conger +1-817-302-5759 (office) +1-214-924-4761 (mobile) [email protected]
CENTURION® Vision System Important Safety Information Caution: Federal (USA) law restricts this device to sale by, or on the order of, a physician. As part of a properly maintained surgical environment, it is recommended that a backup IOL Injector be made available in the event the AutoSert® IOL Injector Handpiece does not perform as expected. Indication: The CENTURION® Vision system is indicated for emulsification, separation, irrigation, and aspiration of cataracts, residual cortical material and lens epithelial cells, vitreous aspiration and cutting associated with anterior vitrectomy, bipolar coagulation, and intraocular lens injection. The AutoSert® IOL Injector Handpiece is intended to deliver qualified AcrySof® intraocular lenses into the eye following cataract removal. The AutoSert® IOL Injector Handpiece achieves the functionality of injection of intraocular lenses. The AutoSert® IOL Injector Handpiece is indicated for use with the AcrySof® lenses SN6OWF, SN6AD1, SN6AT3 through SN6AT9, as well as approved AcrySof® lenses that are specifically indicated for use with this inserter, as indicated in the approved labeling of those lenses. Warnings: Appropriate use of CENTURION® Vision System parameters and accessories is important for successful procedures. Use of low vacuum limits, low flow rates, low bottle heights, high power settings, extended power usage, power usage during occlusion conditions (beeping tones), failure to sufficiently aspirate viscoelastic prior to using power, excessively tight incisions, and combinations of the above actions may result in significant temperature increases at incision site and inside the eye, and lead to severe thermal eye tissue damage. Good clinical practice dictates the testing for adequate irrigation and aspiration flow prior to entering the eye. Ensure that tubings are not occluded or pinched during any phase of operation. The consumables used in conjunction with ALCON® instrument products constitute a complete surgical system. Use of consumables and handpieces other than those manufactured by Alcon may affect system performance and create potential hazards. AEs/Complications: Inadvertent actuation of Prime or Tune while a handpiece is in the eye can create a hazardous condition that may result in patient injury. During any ultrasonic procedure, metal particles may result from inadvertent touching of the ultrasonic tip with a second instrument. Another potential source of metal particles resulting from any ultrasonic handpiece may be the result of ultrasonic energy causing micro abrasion of the ultrasonic tip. ATTENTION: Refer to the Directions for Use and Operator’s Manual for a complete listing of indications, warnings, cautions and notes.
1 Data on File, Alcon Laboratories 2 Vasavada, A.R.,et al. Comparison of torsional and microburst longitudinal phacoemulsification: a prospective, randomized, masked clinical trial. Ophthalmic Surg Lasers Imaging, 2010. 41(1): p. 109-14. 3 Cionni, R.J., A.S. Crandall, and D. Felsted, Length and frequency of intraoperative occlusive events with new torsional phacoemulsification software. J Cataract Refract Surg, 2011. 37(10): p. 1785-90.